The Medical Devices sector report, “Minimally Invasive Surgical (MIS) devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update' provides comprehensive information about the Minimally Invasive Surgical (MIS) devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Minimally invasive surgery (MIS) is a term used to describe either a smaller incision (typically half of the length of the traditional incision) or an approach that does not involve cutting tendons or splitting muscles.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Minimally invasive surgery (MIS) is a term used to describe either a smaller incision (typically half of the length of the traditional incision) or an approach that does not involve cutting tendons or splitting muscles.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Minimally Invasive Surgical (MIS) devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Minimally Invasive Surgical (MIS) devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Minimally Invasive Surgical (MIS) devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Minimally Invasive Surgical (MIS) devices - Pipeline Products under Development by Companies
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Actuated Medical Inc
- BariaTek Medical SAS
- Boston Scientific Corp
- Delft University of Technology
- Distalmotion SA
- Eindhoven University of Technology
- ES Vascular Ltd.
- Ethicon Endo-Surgery Inc
- Ezisurg Medical Co Ltd
- GT Metabolic Solutions
- Imperial College London
- Intuitive Surgical Inc
- Jiangsu Jiyuan Medical Technology Co Ltd
- Johns Hopkins University
- Lapovations LLC
- LXS Inc
- Medacta Group SA
- NanoLite Systems Inc
- Osaka University
- Prana Thoracic Inc
- Purdue University
- Qingdao Jianxin Medical Technology Co Ltd
- Rambam Health Care Campus
- Ronovo Surgical (Shanghai) Medical Science and Technology Ltd
- Signum Surgical Ltd
- Stanford University
- UltraSurge Technologies Ltd.
- University of South Florida
- University of Wisconsin Madison
- Varada Innovations Inc.
- VenX Medical LLC (Inactive)
- Virginia Commonwealth University
- West Virginia University